{"filing":{"accession_number":"0001437749-26-029024","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-08-26","report_date":"2026-08-24","primary_document":"amix20260826_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926029024/amix20260826_8k.htm"},"events":[{"id":29820,"run_id":27316,"accession_number":"0001437749-26-029024","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Autonomix Medical entered into a warrant inducement agreement under which it issued unregistered Series E-1 and Series E-2 warrants (collectively 1,071,826 warrant shares) to an investor in exchange for the investor's exercise of existing warrants, generating approximately $4.9 million in gross proceeds. The new warrants are exercisable at $6.25 per share with 5-year terms and were issued pursuant to Section 4(a)(2) exemption as a private placement of unregistered equity securities.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-08-26","form":"8-K","submitted_at":null,"items":[{"id":32222,"accession_number":"0001437749-26-029024","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical entered into a warrant inducement agreement under which it issued unregistered Series E-1 and Series E-2 warrants (collectively 1,071,826 warrant shares) to an investor in exchange for the investor's exercise of existing warrants. This is a private placement of equity securities (warrants) pursuant to Section 4(a)(2) exemption, generating approximately $4.9 million in gross proceeds. The issuance of new unregistered warrants with dilutive potential (exercisable at $6.25/share with 5-year terms) in exchange for cash proceeds is characteristic of a dilutive equity issuance, though the primary mechanism here involves warrant inducement rather than a traditional PIPE or convertible note.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32223,"accession_number":"0001437749-26-029024","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Autonomix Medical issued unregistered Series E-1 and E-2 warrants (collectively the \"New Warrants\") to purchase 1,071,826 shares of common stock in a private placement pursuant to Section 4(a)(2) exemption. The press release explicitly states these are \"unregistered\" securities offered in a \"private placement\" and describes the transaction as a warrant inducement agreement. This is a classic dilutive equity issuance requiring Item 3.02 disclosure, with material economic impact (approximately $4.9 million in gross proceeds from the underlying warrant exercise).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32224,"accession_number":"0001437749-26-029024","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Autonomix Medical announced a warrant inducement agreement involving the exercise of existing warrants for $4.9 million in gross proceeds and the issuance of new unregistered Series E-1 and E-2 warrants (1,071,826 shares aggregate) to an investor. This is a dilutive capital-raising transaction involving unregistered securities issued in a private placement, characteristic of dilutive issuances at small-cap medical device companies seeking cash.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32222,"accession_number":"0001437749-26-029024","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical entered into a warrant inducement agreement under which it issued unregistered Series E-1 and Series E-2 warrants (collectively 1,071,826 warrant shares) to an investor in exchange for the investor's exercise of existing warrants. This is a private placement of equity securities (warrants) pursuant to Section 4(a)(2) exemption, generating approximately $4.9 million in gross proceeds. The issuance of new unregistered warrants with dilutive potential (exercisable at $6.25/share with 5-year terms) in exchange for cash proceeds is characteristic of a dilutive equity issuance, though the primary mechanism here involves warrant inducement rather than a traditional PIPE or convertible note.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-08-26"},{"id":32223,"accession_number":"0001437749-26-029024","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Autonomix Medical issued unregistered Series E-1 and E-2 warrants (collectively the \"New Warrants\") to purchase 1,071,826 shares of common stock in a private placement pursuant to Section 4(a)(2) exemption. The press release explicitly states these are \"unregistered\" securities offered in a \"private placement\" and describes the transaction as a warrant inducement agreement. This is a classic dilutive equity issuance requiring Item 3.02 disclosure, with material economic impact (approximately $4.9 million in gross proceeds from the underlying warrant exercise).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-08-26"},{"id":32224,"accession_number":"0001437749-26-029024","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Autonomix Medical announced a warrant inducement agreement involving the exercise of existing warrants for $4.9 million in gross proceeds and the issuance of new unregistered Series E-1 and E-2 warrants (1,071,826 shares aggregate) to an investor. This is a dilutive capital-raising transaction involving unregistered securities issued in a private placement, characteristic of dilutive issuances at small-cap medical device companies seeking cash.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-26T21:03:54.582605+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-08-26"}]}